col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


225 Results       Page 1

 [1] 
Elsevier: Journal of Cystic Fibrosis
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―19 Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions Fabiana Ciciriello, Francesco Panariello, Paola Medino, Arianna Biffi, Federico Alghisi, Chiara Rosazza, et al. (+16)
2 [GO] 2023―Nov―03 A multinational report on SARS-COV-2 infection outcomes in people with CF and Aspergillus infection or ABPA Jacob D. Bradbury, Emily Chesshyre, Annalisa Orenti, Andreas Jung, Adilia Warris
3 [GO] 2023―Oct―18 715 Impact of COVID-19 on lung function and nutritional status in cystic fibrosis: a global observational study J. Semenchuk, Y. Naito, S. Charman, S. Cheng, A. Stephenson
4 [GO] 2023―Oct―18 705 Awareness and changes in infection prevention and control practices in cystic fibrosis centers associated with the COVID-19 pandemic M. Ansar, J. Zhou, T. Shields, J. Lipuma, L. Saiman, M. Muhlebach
5 [GO] 2023―Oct―18 471 Comparison of in-clinic only with in-clinic plus virtual mental health screens of adults with cystic fibrosis during the COVID-19 pandemic K. Mertz, M. Ingoldby, T. Vance, A. Lambert
6 [GO] 2023―Oct―18 453 Impact of the COVID-19 pandemic on frequency of clinical visits and physiotherapy adherence of newly diagnosed infants with cystic fibrosis N. Lee Son, M. Richmond, M Chilvers
7 [GO] 2023―Oct―18 71 No SARS-CoV-2 viral upper and lower airways infection in cystic fibrosis: evaluation of clinical outcomes D. Dolce, S. Campana, N. Ravenni, C. Fevola, T. Orioli, E. Camera, et al. (+4)
8 [GO] 2023―Jun―09 P412 A patient-led review of outpatient services following the COVID-19 pandemic and widespread introduction of highly-effective modulator treatments and remote monitoring devices J. Choyce, R. Rashid, N. Patel, J.L. Whitehouse
9 [GO] 2023―Jun―09 P411 Thinking out of the box: twinning in the era of the COVID-19 pandemic M. Boon, L. Brezeanu, M. Vreys, T. Havermans, C. Ruelens, M. Proesmans, et al. (+3)
10 [GO] 2023―Jun―09 P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis C. Smith, P. McCormack, A. Walsh, K.W. Southern
11 [GO] 2023―Jun―09 P394 Comparisons of the personal well-being score (PWS) and health-related quality of life for people with cystic fibrosis before and during the COVID-19 pandemic R. Altabee, S.B. Carr, J. Abbott, R. Cameron, D. Office, N.J. Simmonds, et al. (+3)
12 [GO] 2023―Jun―09 P398 Using the science of health care improvement to implement a virtual cystic fibrosis service post COVID-19 pandemic J. Knowles, N. Pickering, M.K. Dooney, A. Connolly, K. Baker-Wardle, J. Copeland, T. Saba
13 [GO] 2023―Jun―09 P396 Moral distress and burnout in healthcare workers during the COVID-19 pandemic: quantitative results from a large Australian public hospital survey F. Finlayson, H. Dobson, R. Digby, T. Bucknall, C. Malpas, T. Winton-Brown
14 [GO] 2023―Jun―09 P393 Physical activity participation and mental health status of patients with cystic fibrosis during the COVID-19 pandemic: a single centre experience S. Delgado, J. Russo, H. Vincent, D. Fedele
15 [GO] 2023―Jun―09 P395 Completeness of annual review investigations as per national recommendations after the COVID-19 pandemic - experience from a large tertiary centre in the northwest United Kingdom N. Sairally, J. Gooch, A. Myrtle, A. Farquhar, V. Ozkan, A. Maitra
16 [GO] 2023―Jun―09 P256 Impact of COVID-19 pandemic and introduction of CFTR modulator therapy on sputum sampling in a large adult cystic fibrosis (CF) unit K. Gaffney, K. Pollard, C. Etherington, H. Saumtally, M. Denton, I.J. Clifton, D.G. Peckham
17 [GO] 2023―Jun―09 P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis M.S. Suhel, A. Chan, D. Nazareth, D. Wat, M.J. Walshaw, D. Green, F. Frost
18 [GO] 2023―Jun―09 P212 Clinical and transcriptomic features of COVID-19 in cystic fibrosis: a prospective multi-centre study F. Ciciriello, P. Medino, F. Panariello, V. Lucidi, C. Colombo, L. Galietta
19 [GO] 2023―Jun―09 P213 Post-acute sequelae of COVID-19 in children with cystic fibrosis: a case-control study A. Chernyavskaya, O. Simonova, N. Kashirskaya
20 [GO] 2023―Jun―09 P146 COVID-19 pandemic in the Belgian cystic fibrosis patients compared with the international cystic fibrosis patients and the general Belgian population G. Daneau, S. Situma Wanyama, K. Van Hoorenbeeck
21 [GO] 2023―Jun―09 P124 Vaccination situation against COVID-19 in an adults cystic fibrosis center in Argentina E. Baran, C. Canonge, G. Zapitelli, M.V. D’Ascenzo
22 [GO] 2023―Jun―09 P119 Exploring the attitudes and knowledge of the caregivers of children with cystic fibrosis and primary ciliary dyskinesia regarding COVID-19 vaccination A.P. Ergenekon, S. Karabulut, C. Yilmaz Yegit, M. Yanaz, A. Gulieva, M. Kalyoncu, et al. (+7)
23 [GO] 2023―Jun―09 WS07.06 CFTR impacts SARS-CoV-2 infection in cystic fibrosis A. Bragonzi, V. Capurro, C. Cigana, L.J. Galietta, F. Gianferro, I. Pagani, et al. (+3)
24 [GO] 2023―Jun―09 P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis- a single retrospective centre experience J. Sieber, N. Strasser, K. Schmidthaler, E. Dehlink, R. Gaupmann, Z. Szépfalusi, S. Gruber
25 [GO] 2023―Jun―09 P397 Using the science of health care improvement to implement a virtual cystic fibrosis clinic alongside the traditional face-to-face model post-COVID pandemic J. Knowles, T. Saba
26 [GO] 2023―Jun―09 P318 Weight and vitamin D changes in adults with cystic fibrosis in the West of Scotland post induction of triple therapy during a global pandemic F. Moore, D. Mc Tavish
27 [GO] 2023―Jun―09 P037 Home spirometry engagement in a paediatric network post pandemic P. Lawrence, S. Davies, A. Walsh
28 [GO] 2023―Jun―09 P410 The impact of the COVID 19 pandemic and modulator therapy on routine respiratory sampling in paediatric cystic fibrosis (CF) B. Millman, N. Leach, C. Hine, P. Nagakumar, B. Davies, M. Desai
29 [GO] 2023―Mar―13 The use of dornase alfa in patients with COVID-19 Dinesh Sangarran Ramachandram, Chia Siang Kow, Syed Shahzad Hasan
30 [GO] 2022―Oct―03 40 An update from Minnesota on the seroprevalence of COVID-19 immunoglobulin G in our adult population K. Mahan, J. Billings, S. Kiel, J. Dunitz
31 [GO] 2022―Oct―03 50 Multi-center cohort study exploring the impact of the first U.K. COVID-19 lockdown on nebulizer use in adults with cystic fibrosis in the CFHealthHub learning health system L. Lai, R. Sandler, S. Dawson, Z. Hoo, T. Daniels, M. Hutchings, et al. (+3)
32 [GO] 2022―Oct―03 67 Implementation of a health screening process for cystic fibrosis care during the COVID-19 pandemic B. Evangelista, R. Murray, R. List, D. Albon, H. Bruschwein, M. Compton, et al. (+3)
33 [GO] 2022―Oct―03 48 Longitudinal outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic M. Doumit, S. Chuang, P. Middleton, H. Selvadurai, S. Sivam, R. Ruseckaite, et al. (+5)
34 [GO] 2022―Oct―03 37 Trends in Canadian cystic fibrosis health care use amidst the COVID-19 pandemic T. Le, S. Cheng, J. Wallenburg, A. Stephenson
35 [GO] 2022―Oct―03 31 Sleep disturbance and school engagement in children with cystic fibrosis during the COVID-19 pandemic B. Wisniewski, K. Swegheimer, T. Boat, M. Hjelm
36 [GO] 2022―Oct―03 62 Lessons learned from the experience of patients and parents of adaptations in cystic fibrosis care during COVID-19 pandemic in France D. Pougheon, A. Chansard, A. Fanchini, S. Therouanne, P. Lombrail
37 [GO] 2022―Oct―03 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health C. Sakon, H. Vogt, C. Brown, E. Tillman
38 [GO] 2022―Oct―03 221 COVID-19: Evolution of nutritional status in children with cystic fibrosis at the Federico Gomez Children's Hospital in Mexico I. Núñez Barrera, M. Sánchez, J. Lezana Fernández, M. Reyes Apodaca, P. Almada
39 [GO] 2022―Oct―03 51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry S. Cheng, T. Le, J. Wallenburg, J. Sykes, A. Stephenson
40 [GO] 2022―Oct―03 27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers K. Hudock, P. Cheng, J. Chmiel, C. Brown, E. Kramer, V. Indihar, et al. (+4)
41 [GO] 2022―Oct―03 295 Measuring caregiver stress and perceived self-efficacy during a worldwide pandemic A. Delecaris, S. Bilinski, K. Walsh, K. Jones
42 [GO] 2022―Oct―03 314 Cystic fibrosis legal information hotline: A reliable resource for the cystic fibrosis community during the pandemic and beyond B. Sufian, J. Passamano, A. Sopchak
43 [GO] 2022―Oct―03 316 Depression and anxiety scores after highly effective cmodulator therapy in pandemic times in an adult cystic fibrosis clinic J. Blackwelder, V. Indihar, J. Finke, A. Oder, J. Riddle, M. Meyers, et al. (+4)
44 [GO] 2022―Oct―03 366 Attitudes amidst the pandemic: Virtual delivery of care in an adult cystic fibrosis population A. Thomas-Diceman, X. Ma, Z. Gryz, S. Swaleh, J. Sykes, S. Stanojevic, A. Stephenson
45 [GO] 2022―Oct―03 445 Inflammation in normal COVID-19 airway due to inhibition of cystic fibrosis transmembrane conductance regulator signaling by the SARSCoV-2 Spike protein H. Caohuy, O. Eidelman, T. Chen, Q. Yang, N. Walton, H. Pollard
46 [GO] 2022―Oct―03 534 COVID-19 in people with cystic fibrosis and the general population: Severity and virus-host cell interactions C. Colombo, G. Alicandro, A. Bandera, V. Bouché, A. Biffi, M. Boraso, et al. (+9)
47 [GO] 2022―Oct―03 532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis V. Daccò, L. Cariani, G. Alicandro, C. Rosazza, B. Orena, F. Ferraro, et al. (+3)
48 [GO] 2022―Oct―03 485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease P. Hawkins, W. Anderson, S. Leist, K. Okuda, A. Schaefer, R. Gilmore, et al. (+8)
49 [GO] 2022―Oct―03 385 Mechanisms by which cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection P. Tedbury, C. Manfredi, J. Conway, M. Horwath, C. McCracken, A. Sorscher, et al. (+17)
50 [GO] 2022―Oct―03 433 Differential small ribonucleic acid expression analysis reveals transforming growth factor beta role in SARS-CoV-2 infection of the cystic fibrosis airway E. Hejenkowska, N. Mitash, J. Donovan, F. Mu, D. Beer Stolz, C. Bertrand, A. Swiatecka-Urban
51 [GO] 2022―Oct―03 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells C. Sorio, V. Lotti, F. Merigo, A. Lagni, A. Di Clemente, M. Ligozzi, et al. (+7)
52 [GO] 2022―Oct―03 509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis V. Bezzerri, V. Gentili, C. Boni, E. Baldisseri, A. Finotti, C. Papi, et al. (+14)
53 [GO] 2022―Sep―16 Clinical outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic Mr Michael Doumit, Sandra Chuang, Peter Middleton, Hiran Selvadurai, Sheila Sivam, Rasa Ruseckaite, et al. (+5)
54 [GO] 2022―Jun―13 Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: a global observational study Siobhán B Carr, Elliot McClenaghan, Alexander Elbert, Albert Faro, Rebecca Cosgriff, Olzhas Abdrakhmanov, et al. (+31)
55 [GO] 2022―Jun―10 WS20.02 Input supporting a young person with increased cough suppression in the context of COVID-19 A. Shayle, K. Lock
56 [GO] 2022―Jun―10 ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC) F. Lucca, V. Carnovale, R. Casciaro, I. Comello, V. Daccò, E. Ferrara, et al. (+12)
57 [GO] 2022―Jun―10 ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK D. Lau, L. Speight, F. Melindo, A. Prosser, J. Lee, C. Addy, et al. (+2)
58 [GO] 2022―Jun―10 P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population C. Rosazza, P. Medino, A. Bandera, M.S. Boraso, F. Ciciriello, M. Cipolli, et al. (+7)
59 [GO] 2022―Jun―10 ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) K. Braisdell, N.S. West
60 [GO] 2022―Jun―10 ePS1.02 Long-term psychological impact of COVID-19 on adult patients with cystic fibrosis, including transplanted patients T. Havermans, N. Seyen, K. Luyckx, R. Vos, L. Dupont
61 [GO] 2022―Jun―10 ePS1.05 Impact of COVID-19 on mental health among people with cystic fibrosis E.-A. Chrysochoou, E. Hatziagorou, C. Michailidou, M. Gioulvanidou, M. Galogavrou, J. Tsanakas
62 [GO] 2022―Jun―10 ePS4.02 Impact of COVID-19 on the disease course in cystic fibrosis? A Registry-based study J. Vandekerckhove, S.S. Wanyama, G. Daneau, L. Peeters, E. DeWachter
63 [GO] 2022―Jun―10 ePS1.04 Sleep disturbances in children with cystic fibrosis at the beginning and in the first year of the COVID-19 pandemic T. Sismanlar Eyuboglu, A.T. Aslan, T. Ramasli Gursoy, P. Asfuroglu, A.S. Soysal, D. Yapar, M.N. Ilhan
64 [GO] 2022―Jun―10 ePS4.04 Evaluation of burden of the COVID-19 pandemic among the cystic fibrosis community in Brno, Czech Republic M. Mala, L. Homola, E. Pokojova, N. Stastna, A. Holcikova, Z. Gracova
65 [GO] 2022―Jun―10 P256 Change in the anxiety levels of children with cystic fibrosis and their mothers at the beginning of the COVID-19 pandemic and after 1 year P. Asfuroglu, T. Sismanlar Eyuboglu, A. Tana Aslan, T. Ramasli Gursoy, B. Pinar Senkalfa, S. Soysal, et al. (+2)
66 [GO] 2022―Jun―10 P188 Vitamin D status at Bristol Adult CF Centre (BACFC) during the COVID-19 pandemic and following the introduction of the multivitamin Paravit CF A. Keele, J. Read, F. Hameed, D. Bhaskaran, M. Yousif, K. Bateman
67 [GO] 2022―Jun―10 ePS1.06 Evolution of psychological distress during progression of the COVID-19 pandemic in adults with cystic fibrosis F. Cresta, R. Ciprandi, C. Castellani, R. Pescini, R. Casciaro, I. Schiavetti
68 [GO] 2022―Jun―10 P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia I. Markelić, T. Odobašić Palković, I. Bambir, T. Milinković, D. Tješić-Drinković, A. Vukić Dugac
69 [GO] 2022―Jun―10 P184 An evaluation of virtual Cystic Fibrosis-Related Diabetes (CFRD) clinics in the adult service during the COVID-19 pandemic in Northern Ireland (NI) E. Molloy, O. Holmes, D. O’Neill, J. Rendall, A. Nugent
70 [GO] 2022―Jun―10 P073 Observed impact on admissions during the COVID-19 pandemic of paediatric cystic fibrosis patients in a tertiary hospital setting S. Warraich, K. Lock, C. Hamilton, L. Selby
71 [GO] 2022―Jun―10 P257 Who’s talking about cystic fibrosis continued: the effects of the COVID-19 pandemic on the cystic fibrosis online landscape H. Ibrahim, T. Vagg, N.J. Ronan, M. McCarthy, C. Fleming, J. Dorgan, et al. (+3)
72 [GO] 2022―Jun―10 ePS1.07 Parental experiences of face-to-face versus virtual cystic fibrosis clinics during the COVID-19 pandemic: questionnaire study K. Lock, L. Lowndes, Z. Johnstone, W. Kozlowska
73 [GO] 2022―Jun―10 P076 COVID-19 vaccination in children and adolescents with cystic fibrosis - a single-centre experience A. Zver, M. Praprotnik, M. Aldeco, D. Lepej, S. Šetina Šmid, J. Rodman Berlot, U. Krivec
74 [GO] 2022―Jun―10 ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia I. Bambir, I. Todoric, L. Omerza, T. Milinkovic, I. Markelic, T. Odobasic Palkovic, et al. (+2)
75 [GO] 2022―Jun―10 P075 COVID-19 vaccination uptake in patients with cystic fibrosis D.-E. Manning, L. Speight, A. Prosser, J. Duckers
76 [GO] 2022―Jun―10 ePS4.08 COVID-19 vaccine uptake in adult people with cystic fibrosis M.H. Mir, T. FitzMaurice, D. Wat, G. Aldous, D. Nazareth, M. Walshaw
77 [GO] 2022―Jun―10 ePS4.05 Evolving cystic fibrosis care during COVID-19: a single-centre experience G. Spoletini, C. Campbell, C. Etherington, K. Pollard, N. Burke, D. Shimmin, et al. (+2)
78 [GO] 2022―Jun―10 WS20.06 Co-infection with Nocardia farcinia and SARS-CoV-2 causing the death of an adolescent with cystic fibrosis J. Chapman, F. Gilchrist, S. Driscoll, K. Bakewell, R. Fishwick, S.-A. Ho, W. Carroll
79 [GO] 2022―Jun―10 ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis G. Alicandro, V. Dacco’, L. Cariani, M. Contarini, C. Rosazza, C.S. Sciarrabba, et al. (+3)
80 [GO] 2022―Jun―10 P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience A. Vidoevska, T. Jakovska, S. Momchilovik, I. Arnaudova-Danevska, E. Ginovska-Tasevska
81 [GO] 2022―Jun―10 WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells V. Lotti, F. Merigo, A. Lagni, A. Di Clemente, M. Ligozzi, P. Bernardi, et al. (+7)
82 [GO] 2022―Jun―10 ePS4.01 The impact of the SARS-CoV-2 pandemic on people with cystic fibrosis (CF) in Ireland: did individuals maintain their key health outcomes? H. Rees, S. Babu, R. Doherty, G. Fletcher, S. Joshy, P. O’Regan, L. Kirwan
83 [GO] 2022―Jun―10 ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single-centre case series F. Gautschi, R. Hage, C. Steinack, M.M. Schuurmans
84 [GO] 2022―Apr―14 Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis Athanasios Michos, Filippos Filippatos, Elisabeth-Barbara Tatsi, Charilaos Dellis, Vasiliki Efthymiou, Ioanna Zarkada, et al. (+3)
85 [GO] 2022―Feb―21 THE CLINICAL IMPACT OF THE COVID-19 PANDEMIC FIRST WAVE ON PATIENTS WITH CYSTIC FIBROSIS IN NEW YORK] Joseph L. Simonson, Christine Esposito, Theresa Frantzen, Katherine Henthorne, Aileen Espinal, Serena Romano, et al. (+27)
86 [GO] 2022―Feb―16 Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over Gianfranco Alicandro, Valeria Daccó, Lisa Cariani, Martina Contarini, Letizia Corinna Morlacchi, Chiara Rosazza, et al. (+7)
87 [GO] 2021―Dec―18 Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis Beth A. Smith, Anna M. Georgiopoulos, Amy Mueller, Janice Abbott, Paula Lomas, Enid Aliaj, Alexandra L. Quittner
88 [GO] 2021―Dec―18 Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis (Commentary) Trudy Havermans
89 [GO] 2021―Dec―18 Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic George M. Solomon, Julianna Bailey, James Lawlor, Peter Scalia, Gregory S. Sawicki, Christopher Dowd, et al. (+2)
90 [GO] 2021―Dec―18 Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic Christopher Dowd, Aricca D. Van Citters, Olivia Dieni, Anne Willis, Leslie Powell, Kathryn A. Sabadosa
91 [GO] 2021―Dec―18 Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs Alex H. Gifford, Thida Ong, Christopher Dowd, Aricca D. Van Citters, Peter Scalia, Kathryn A. Sabadosa, Gregory S. Sawicki
92 [GO] 2021―Dec―18 Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future Gregory S. Sawicki, Aricca D. Van Citters, Olivia Dieni, Kathryn A. Sabadosa, Anne Willis, Debbie Benitez, et al. (+2)
93 [GO] 2021―Dec―18 Financial impacts of the COVID-19 pandemic on cystic fibrosis care: Lessons for the future (Commentary) A.L. Stephenson Anne L. Stephenson
94 [GO] 2021―Dec―18 Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members Aricca D. Van Citters, Olivia Dieni, Peter Scalia, Christopher Dowd, Kathryn A. Sabadosa, Jill D. Fliege, et al. (+3)
95 [GO] 2021―Dec―18 Impact of the COVID-19 pandemic: How our response is shaping the future of cystic fibrosis care Kathryn A. Sabadosa, Albert Faro, Eugene C. Nelson, Bruce C. Marshall
96 [GO] 2021―Dec―18 Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors Dana Albon, Aricca D. Van Citters, Thida Ong, Olivia Dieni, Christopher Dowd, Anne Willis, et al. (+5)
97 [GO] 2021―Dec―13 SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: a seroprevalence study in two specialized centres in Northern Italy Gianfranco Alicandro, Valeria Daccó, Lisa Cariani, Martina Contarini, Letizia Corinna Morlacchi, Chiara Rosazza, et al. (+6)
98 [GO] 2021―Nov―14 Management of Cystic Fibrosis during COVID-19: Patient Reported Outcomes based remote follow-up among CF patients in Denmark - A feasibility study Lotte Rodkjær, Majbritt Jeppesen, Liv Schougaard
99 [GO] 2021―Oct―19 76: Sustaining routine cystic fibrosis care in a large pediatric CF program during COVID-19 R. Gordon, K. Barnico, G. Sawicki, M. Harrison
100 [GO] 2021―Oct―19 152: Weekly patient-family-staff-volunteer during COVID-19 G. Raissi, N. Patel, R. Casey, B. Corcoran, H. Sadeghi
101 [GO] 2021―Oct―19 335: Greater access to mental health care with CF team psychologist through telemedicine during COVID-19 S. Filigno, E. Hente, M. Lisa, C. Siracusa
102 [GO] 2021―Oct―19 58: Seroprevalence of COVID-19 IgG in the cystic fibrosis population K. Mahan, J. Billings, S. Kiel, S. Sultan, J. Dunitz, B. Noren, et al. (+2)
103 [GO] 2021―Oct―19 346: Tennessee cystic fibrosis clinical care during the COVID-19 pandemic F. Cacho, S. Srinivasan, R. Schoumacher, R. Hamilton, J. Ledbetter, M. Moser, et al. (+8)
104 [GO] 2021―Oct―19 334: Addressing food insecurity and mental health during the COVID-19 pandemic L. Weaver, M. Reed, A. Chidekel
105 [GO] 2021―Oct―19 310: Physically distant but virtually together: CF community-based webcasts during the COVID-19 pandemic A. Uluer, S. Rits, C. Snell, M. Alao, I. Bailey, C. Huysman, et al. (+10)
106 [GO] 2021―Oct―19 296: Mental health implications of genetic modulator therapy in CF: Depression and anxiety screening for pediatric patients prescribed elexacaftor/tezacaftor/ivactor during the COVID-19 pandemic T. Vance, M. Finch, D. Bauer, M. Sachs, S. Landvik, J. McNamara
107 [GO] 2021―Oct―19 274: Creating a virtual CF support group for adolescents during the COVID-19 pandemic E. Jorgensen, Z. Held, S. Garcha, C. Courtlandt, D. Schellhase
108 [GO] 2021―Oct―19 269: Food security and nutritional adherence in adolescents with cystic fibrosis during the COVID-19 pandemic K. Durkin, J. Kelleher, L. Stark, K. Griffin, C. Lynn, S. Filigno, et al. (+4)
109 [GO] 2021―Oct―19 239: Perspectives of people with CF and caregivers regarding medication access and telehealth in CF care during the COVID-19 pandemic H. Phan, E. Hall Lipsy, K. McCulley, E. Vuong, K. Anderson, A. Sharpe, A. Bowen
110 [GO] 2021―Oct―19 188: Cystic fibrosis kidney stone disease in the era of CFTR modulator use and the COVID-19 pandemic S. Romano, T. Frantzen, G. LaVecchia, J. Wang
111 [GO] 2021―Oct―19 177: Impact of elexacaftor/tezacaftor/ivacaftor therapy use on pulmonary exacerbation rates during the COVID-19 pandemic E. Menten, T. Saroya, E. DiMango, C. Keating
112 [GO] 2021―Oct―19 166: Reliability of a home spirometer for monitoring children with cystic fibrosis during the COVID-19 pandemic D. Mager, C. James-Boldewijn, D. Archangel, S. Lever, H. Janssens
113 [GO] 2021―Oct―19 113: Addressing food insecurity among patients with CF during the COVID-19 pandemic W. Sewell, D. Sadeghi, G. Raissi, B. Corcoran, H. Sadeghi
114 [GO] 2021―Oct―19 110: Real-world outcomes in cystic fibrosis telehealth clinical care during the COVID-19 pandemic L. Somerville, R. List, M. Compton, H. Bruschwein, D. Jennings, R. Murray, et al. (+5)
115 [GO] 2021―Oct―19 107: A new statewide consortium of cystic fibrosis care centers formed during the COVID-19 pandemic S. Srinivasan, R. Brown, J. Ledbetter, D. Quintero
116 [GO] 2021―Oct―19 83: CF Global Care: Continuation of the collaboration between 2 CF centers; University of Michigan, USA, and Marmara University, Istanbul, Turkey, in the COVID-19 pandemic S. Nasr, Y. Gökdemir, E. Erdem Eralp, F. Karakoc, P. Ergenekon, C. Tapley, et al. (+5)
117 [GO] 2021―Oct―19 79: A patient satisfaction survey regarding the use of telemedicine for outpatient CF endocrinology and diabetes care during the COVID-19 pandemic S. Soltman, D. Gardner, A. Swift
118 [GO] 2021―Oct―19 14: Pregnancy and outcomes in the era of CFTR modulators and COVID-19 pandemic S. Li, A. Patel, J. Heintz, A. Nance, A. Rice, K. Sakellaris, et al. (+5)
119 [GO] 2021―Oct―19 44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study S. Cheng, T. Le, M. McIlwaine, I. McIntosh, J. Wallenburg, A. Stephenson
120 [GO] 2021―Oct―19 314: The COVID-19 pandemic and trends in anxiety and depressive symptoms in adolescents with cystic fibrosis and their caregivers S. Szentpetery, K. Foil, L. Christon
121 [GO] 2021―Oct―19 71: Collection of expectorated sputum or oral pharyngeal cultures during initial period of the COVID-19 pandemic in a pediatric cystic fibrosis clinic J. Hamilton, S. Meihls, H. Toledo, A. Snuggerud, S. Spade Warren
122 [GO] 2021―Oct―19 333: Perceptions of telehealth of patients with cystic fibrosis and their caregivers during the COVID-19 pandemic in Australia R. Ruseckaite, J. Herdiman, S. Ahern
123 [GO] 2021―Oct―19 276: Effects of COVID-19 pandemic on adult cystic fibrosis patients’ mental health P. Chen, D. Finklea, L. Cohen, R. Jain, K. Lowe, G. Ratti, et al. (+2)
124 [GO] 2021―Oct―19 41: COVID-19 pandemic restrictions have long-term impact on physical activity in adults with cystic fibrosis T. Radtke, S. Haile, H. Dressel, C. Benden
125 [GO] 2021―Oct―19 131: Home spirometry utilization in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: A quality improvement process M. Compton, R. List, E. Starheim, L. Williamson, D. Jennings, L. Gettle, et al. (+4)
126 [GO] 2021―Oct―19 266: Physiotherapy during the COVID-19 pandemic: Support for the shielding patient by the shielding physiotherapist J. Carson, L. Alexander, J. Bell
127 [GO] 2021―Oct―19 235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center E. Elson, E. Meier, P. Capel, J. Haynes, M. Fischer, S. Duehlmeyer, C. Oermann
128 [GO] 2021―Oct―19 54: Evaluating COVID-19 Vaccine Hesitancy at the New Orleans Adult CF Care Center J. Bodnar, E. Sheffield, R. Klingsberg, C. Bojanowski
129 [GO] 2021―Oct―19 340: Challenges in obtaining COVID-19 vaccines: Bridging the gap for rural northeast Texas cystic fibrosis patients C. Guthrie, T. Sadler, C. Wadle, E. Dohanich, L. Couch
130 [GO] 2021―Oct―19 337: Food insecurity in the cystic fibrosis care center network during COVID-19: Prevalence, screening, and interventions J. Bailey, G. Brown, M. Corbera-Hincapie, C. Clemm, E. Dasenbrook, D. Durham, et al. (+5)
131 [GO] 2021―Oct―19 336: Compass trends and the potential impact of coronavirus R. Scott, B. McCreery-Cullifer, K. Muldowney, A. Stocks, A. Kaider
132 [GO] 2021―Oct―19 416: Expression of SARS-CoV-2 entry genes is not greater in the nasal mucosa of CF patients M. Sala, N. Markov, A. Misharin, M. Jain
133 [GO] 2021―Oct―19 382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins A. Recchiuti, S. Patruno, D. Mattoscio, E. Isopi, A. Pomilio, R. Pecce, M. Romano
134 [GO] 2021―Oct―19 496: Reduced susceptibility of mice with CF-like lung disease to SARS-CoV-2 infection P. Hawkins, K. Okuda, S. Leist, A. Schafër, R. Gilmore, A. Volmer, et al. (+6)
135 [GO] 2021―Oct―19 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis G. Hergenroeder, J. Cogen, A. Genatossio, S. McNamara, M. Pascual, R. Hernandez
136 [GO] 2021―Oct―19 159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis T. Kremer, I. St Onge, M. Trivedi, F. Dy, C. Bielick, D. Fish, et al. (+3)
137 [GO] 2021―Oct―19 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study A. Blanchard, S. Hewko, R. Somayaji, J. Cogen, R. Hernandez, A. Stephenson, et al. (+6)
138 [GO] 2021―Oct―19 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study R. Hernandez, J. Cogen, A. Blanchard, V. Waters, D. Downey, L. Hoffman, et al. (+10)
139 [GO] 2021―Oct―19 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF S. Nakano, K. Okuda, C. Edwards, H. Dang, T. Asakura, T. Kato, et al. (+12)
140 [GO] 2021―Oct―19 410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2 M. Ruffin, J. Bigot, C. Calmel, J. Mercier, A. Pizzorno, M. Rosa-Calatrava, et al. (+4)
141 [GO] 2021―Oct―19 343: Impact of the SARS-CoV-2 pandemic and a food pantry on food insecurity in a pediatric cystic fibrosis center H. Holzum, K. Nelson, J. Granneman, J. Acton, R. Nevel
142 [GO] 2021―Oct―19 156: Pre-procedural Sars-CoV-2 testing and pulmonary function testing I. St Onge, F. Dy, M. Trivedi, J. Longtine, K. Longtine, D. Fish, et al. (+3)
143 [GO] 2021―Oct―19 81: Maintaining routine cystic fibrosis sputum surveillance during the pandemic J. Seguin, J. Cary, T. Hatch, P. Scharoun, A. Grzymkowski, C. Fortner, et al. (+2)
144 [GO] 2021―Oct―19 61: Improving CFRD screening in a pediatric CF center during a pandemic J. Stewart, A. Snuggerud, S. Meihls, S. Spade Warren, H. Toledo, F. Asfour
145 [GO] 2021―Oct―19 299: Stress and mental health in cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample S. Graziano, F. Boldrini, V. Lucidi, P. Tabarini
146 [GO] 2021―Oct―19 344: Initiating food insecurity screening during a pandemic: Identifying and overcoming barriers J. Fulton, M. Koons, H. Torres, A. Gray, S. Martin, J. Hoppe
147 [GO] 2021―Oct―19 338: A serendipitous role of telehealth in postpandemic CF care J. Makhija, S. Samantha, C. Forseen, V. Taskar, J. Yap
148 [GO] 2021―Sep―24 Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care J Stuart Elborn
149 [GO] 2021―Sep―11 Telehealth after the pandemic: Will the inverse care law apply? Rebecca J Calthorpe, Alan R. Smyth
150 [GO] 2021―Sep―02 Commentary on: “Evaluating barriers and promotors of telehealth during the COVID-19 pandemic at cystic fibrosis programs to inform new models of CF care” Sarath C. Ranganathan
151 [GO] 2021―Jun―11 P088 Impact of COVID-19 and cocooning on employment of people with cystic fibrosis R. Bhatnagar, S. Tecklenborg, R. Segurado, P. Fitzpatrick
152 [GO] 2021―Jun―11 P179 Has COVID-19 affected the management of vitamin D status amongst people with cystic fibrosis? A. Ochota, S. Pandya, M. Walshaw
153 [GO] 2021―Jun―11 P227 Cystic fibrosis social workers’ experience of working during COVID-19 F. Dowdall, A. Tansinda, M. Donnelly, S. Chandran
154 [GO] 2021―Jun―11 EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis E. Hatziagorou, P. Peftoulidou, I. Toulia, E. Tasika, E.-A. Chrysochoou, J. Tsanakas
155 [GO] 2021―Jun―11 EPS1.04 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis Z. Johnstone, J. Hyson
156 [GO] 2021―Jun―11 P089 Coronavirus infection (COVID-19) in children with cystic fibrosis of the Russian Federation E. Kondratyeva, A. Gorelov, E. Zhekaite, S. Nikolaeva, V. Sherman, O. Simonova, et al. (+4)
157 [GO] 2021―Jun―11 P137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort C. Steinack, R. Hage, F. Gautschi, M.M. Schuurmans
158 [GO] 2021―Jun―11 P208 Anxiety, depression and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers M. Verkleij, L. Noij, S. Hashimoto, S. Terheggen-Lagro, J. Altenburg, E. Haarman
159 [GO] 2021―Jun―11 P086 The impact of COVID-19 in people with cystic fibrosis - a single-centre experience G. Aldous, N. Pinnock, D. Nazareth, M. Walshaw
160 [GO] 2021―Jun―11 P136 Relationship between cystic fibrosis disease severity and susceptibility to COVID-19 infection M. Atalay, N. Emiralioĝlu, U. Özçelik, E. Yalçın, D. Doĝru, N. Kiper, D. Dayangaç Erden
161 [GO] 2021―Jun―11 EPS2.07 How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland? M. Mielus, M. Surowiecka, P. Madej, K. Zybert, D. Sands
162 [GO] 2021―Jun―11 EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics E. Scott, M. Ledson, M. Walshaw
163 [GO] 2021―Jun―11 P085 Impact of COVID-19 on hospital services and specialist care of adults with cystic fibrosis R. Bhatnagar, S. Tecklenborg, R. Segurado, P. Fitzpatrick
164 [GO] 2021―Jun―11 P087 Impact of COVID-19 on mental health of children with cystic fibrosis and their parents R. Bhatnagar, S. Tecklenborg, R. Segurado, P. Fitzpatrick
165 [GO] 2021―Jun―11 EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK C. Brown, M. Archer, L. Carson, N. Collins, T. Daniels, A. Gates, et al. (+4)
166 [GO] 2021―Jun―11 P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team S. Jones, L. Smith, K. Ainsworth
167 [GO] 2021―Jun―11 P229 Children and young people with cystic fibrosis enhanced multidisciplinary pathways to address their educational needs during the evolving COVID-19 pandemic S. Chandran, M. Panayi
168 [GO] 2021―Jun―11 P230 A review of paediatric cystic fibrosis care during the COVID-19 pandemic L. Powell, J. Watkinson, N. Rao
169 [GO] 2021―Jun―11 P226 A survey of family experience of cystic fibrosis care during the COVID-19 pandemic J. Watkinson, L. Powell, N. Rao
170 [GO] 2021―Jun―11 P225 Parents’ feedback on virtual paediatric cystic fibrosis clinics during COVID-19 pandemic M. Powell, R. Rees, L. John, R. Street, R. Evans
171 [GO] 2021―Jun―11 P218 Detection of anxiety and depression through mental health screening questionnaires in cystic fibrosis patients and their families during the COVID-19 pandemic A. Morales Tirado, E. Blitz Castro, S. Vicente Santamaría, A. Lamas Ferreiro, M.F. Pando, P. Fernández Martín, et al. (+6)
172 [GO] 2021―Jun―11 P211 Use of telemedicine for mental health screening during the COVID-19 pandemic H. Bruschwein, M. Soper, D. Jennings, L. Somerville, R. List, M. Compton, et al. (+4)
173 [GO] 2021―Jun―11 P172 Patient experience of Manchester Virtual Cystic Fibrosis-Related Diabetes Clinic during the COVID-19 pandemic A. Brennan, J. Pickles, S. Punt, K. Taylor, J. Beynon
174 [GO] 2021―Jun―11 P157 Monitoring the distribution and genotypic diversity of Burkholderiales bacteria in Russian cystic fibrosis patients in the year of the COVID-19 pandemic O. Voronina, N. Ryzhova, M. Kunda, E. Aksenova, A. Lasareva, O. Simonova, et al. (+3)
175 [GO] 2021―Jun―11 P138 Rapid implementation of virtual clinics during the COVID-19 pandemic D. Nazareth, C. Sumner, M. Walshaw
176 [GO] 2021―Jun―11 P094 Facilitating cystic fibrosis research during the COVID-19 pandemic S. Burnett, M. Preidt, T. FitzMaurice, M. Walshaw, D. Nazareth
177 [GO] 2021―Jun―11 P091 Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic I. Todorić, I. Bambir, I. Markelić, L. Omerza, T. Milinković, T. Odobašić Palković, et al. (+4)
178 [GO] 2021―Jun―11 P090 A UK survey on changes in managing people with cystic fibrosis during the COVID-19 pandemic M.S. Hameed, A. Kumar, C. Baker, D. Nazareth, M. Walshaw
179 [GO] 2021―Jun―11 EPS1.01 Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic M. Mittaine, E. Aversenq, P. Milhorat, C. Lannibois, P. Maumus, A. Arrouy
180 [GO] 2021―Jun―11 WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic K. Richards, S. Geoghegan, M. Butler, N. Shafi, D. Watson
181 [GO] 2021―Jun―11 WS11.1 The anxiety levels of children with cystic fibrosis and healthy children during the COVID-19 pandemic A.P. Ergenekon, M. Cenk, C. Yilmaz Yegit, M. Yuksel, A. Guliyeva, A. Toksoy Aksoy, et al. (+6)
182 [GO] 2021―Jun―11 EPS1.09 Adapting services during the COVID-19 pandemic - a patient evaluation of physiotherapy telephone reviews within multidisciplinary team virtual clinics S. Fitzgerald, C. Lathia, P. Wilson.
183 [GO] 2021―Jun―11 P092 Embedding an electronic patient record into a developing UK service and impact during the COVID-19 pandemic - Blackpool Adult Cystic Fibrosis Service (BACFS) N. Pickering, T. Saba
184 [GO] 2021―Jun―11 P223 The role of psychologist in a cystic fibrosis centre during the COVID-19 pandemic - experience of a Polish paediatric centre U. Borawska-Kowalczyk, A. Sujecka, M. Mielus, D. Sands
185 [GO] 2021―Jun―11 P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre? N. Iqbal, Z. Nadat, J.E. Vessey, K.J. Martin, A.L. Brennan, R.J. Bright-Thomas, et al. (+3)
186 [GO] 2021―Jun―11 P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre L. Warnock, W. Flight, K. Chapman, A. Gates
187 [GO] 2021―Jun―11 WS14.4 Exploring cystic fibrosis patient and staff perceptions of the Virtual Healthcare Hub during the COVID-19 pandemic at the All Wales Adult Cystic Fibrosis Service E. Birkin, C. Bridges, L. Speight, C. O'Leary, J. Duckers
188 [GO] 2021―Jun―11 P221 Quality of life in adult and children with cystic fibrosis during the COVID-19 pandemic in Croatia T. Odobasic Palkovic, T. Milinkovic, I. Markelic, F. Džubur, I. Godic, I. Barbir, et al. (+2)
189 [GO] 2021―Jun―11 P139 Evaluating the impact of a telemedicine service during the COVID-19 pandemic in people with cystic fibrosis A. Bull, T.S. FitzMaurice, D. Nazareth, M. Walshaw
190 [GO] 2021―Jun―11 WS14.1 The effect of the COVID-19 pandemic on quality of life of adults with cystic fibrosis E. Birkin, L. Speight, A. Smith, C. Oleary, J. Duckers
191 [GO] 2021―Jun―11 P219 Before and during the COVID-19 pandemic: a review of health of our paediatric cystic fibrosis patients L. Powell, J. Watkinson, N. Rao
192 [GO] 2021―Jun―11 P224 Change in care during the COVID-19 pandemic: single-centre experience in a middle-income setting E. Hatziagorou, I. Toulia, E. Kalaitzidou, E-A Chrysochoou, M. Galogavrou, J. Tsanakas
193 [GO] 2021―Jun―11 EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK A. Connolly, J. Knowles, M. Etumi
194 [GO] 2021―Jun―11 EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2 C. Schwarz, M. Lackner, P. Eschenhagen, M. Nagl
195 [GO] 2021―Jun―11 WS14.5 SARS-CoV-2 driving rapid change in cystic fibrosis services: the role of the clinical nurse specialist R. Dunk, S. Madge
196 [GO] 2021―Jun―11 P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group C. Colombo, G. Alicandro, V. Daccó, V. Gagliano, L.C. Morlacchi, R. Casciaro, et al. (+11)
197 [GO] 2021―Jun―11 P135 SARS-COV-2 infection in patients with cystic fibrosis L. Balanetchi, E. Gudumac, D. Rotaru-Cojocari, R. Selevestru, S. Sciuca
198 [GO] 2021―Jun―11 P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study E. McClenaghan, R. Cosgriff, K. Brownlee, S. Ahern, P.-R. Burgel, C.A. Byrnes, et al. (+29)
199 [GO] 2021―Jun―11 P231 Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England A. Sanderson-Thomas, N. Pickering, T. Saba
200 [GO] 2021―Jun―11 P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany D. Dolce, N. Ravenni, M. Francalanci, S. Campana, E. Camera, G. Mergni, et al. (+6)
201 [GO] 2021―Jun―11 P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020 S. Van Koningsbruggen-Rietschel, V. Bulteel, F. Dunlevy, K. Hayes, A. Verbrugge, D. Downey
202 [GO] 2021―Jun―11 P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry H. Rees, S. Babu, G. Fletcher, L. Kirwan
203 [GO] 2021―Jun―11 P222 Supporting children with cystic fibrosis: building social networks through the pandemic E. Lee Mindel
204 [GO] 2021―Jun―11 P140 TeCC (TeleMedicine, Cystic Fibrosis, Corona-Virus) study in a previous telemedicine-naive centre: clinical challenges, outcomes, and user experience in the first six months of a global pandemic D. Morrissy, T. Vagg, M. McCarthy, J. Dorgan, C. Fleming, C. Howlett, et al. (+2)
205 [GO] 2021―Jun―11 P051 Rollout of Kaftrio® to adult cystic fibrosis patients at the Royal Brompton Hospital during a global pandemic E. Bowman, C. Caldwell, A. Jones, S. Madge
206 [GO] 2021―Jun―11 P203 Fertile ground: pregnancies in a post-Kaftrio® pandemic era A. Lillis, S. Lorca-Mayor, P. Weldon, E. Marsh, S. Collins, C. Lathia, et al. (+5)
207 [GO] 2021―Jun―05 Speaking of pandemics... Michael S. Schechter
208 [GO] 2021―Apr―19 Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 Naehrlich Lutz, Orenti Annalisa, Dunlevy Fiona, Kasmi Irena, Harutyunyan Satenik, Pfleger Andreas, et al. (+64)
209 [GO] 2021―Apr―16 COVID-19 vaccine prioritisation for people with cystic fibrosis Siobhán B Carr, Rebecca Cosgriff, Satenik Harutyunyan, Peter G Middleton, Rasa Ruseckaite, Susannah Ahern, et al. (+32)
210 [GO] 2021―Apr―08 SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: an unfavourable conjunction? C. Olcese, R. Casciaro, D. Pirlo, C. Debbia, E. Castagnola, F. Cresta, C. Castellani
211 [GO] 2021―Mar―27 Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19 Davis Jaclyn, NeSmith Andrew, Perkins Ryan, Bailey Julianna, Siracusa Christopher, Chaudary Nauman, et al. (+3)
212 [GO] 2021―Jan―26 To the Editor of Journal of Cystic Fibrosis: First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: data from Italian Cystic Fibrosis Registry Rita Padoan, Marco Salvatore
213 [GO] 2020―Dec―23 PSYCHOLOGICAL DISTRESS IN ADULTS WITH AND WITHOUT CYSTIC FIBROSIS DURING THE COVID-19 LOCKDOWN Riccardo Ciprandi, Maurizio Bonati, Rita Campi, Rita Pescini, Carlo Castellani
214 [GO] 2020―Dec―17 The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network Kelsie Pearson, Nicole Mayer-Hamblett, Christopher H. Goss, George Z. Retsch-Bogart, Jill M. VanDalfsen, Patricia Burks, et al. (+4)
215 [GO] 2020―Dec―03 Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study Robert Bain, Rebecca Cosgriff, Marco Zampoli, Alexander Elbert, Pierre-Régis Burgel, Siobhán B Carr, et al. (+19)
216 [GO] 2020―Nov―20 ALPHA-1 ANTITRYPSIN FOR CYSTIC FIBROSIS COMPLICATED BY SEVERE CYTOKINEMIC COVID-19 Oliver J McElvaney, Eoin O'Connor, Natalie L McEvoy, Daniel D Fraughan, Jennifer Clarke, Oisín F McElvaney, et al. (+4)
217 [GO] 2020―Nov―05 The global impact of SARS-CoV-2 in 181 people with cystic fibrosis Elliot McClenaghan, Rebecca Cosgriff, Keith Brownlee, Susannah Ahern, Pierre-Régis Burgel, Catherine A Byrnes, et al. (+27)
218 [GO] 2020―Aug―28 Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis Thomas Radtke, Sarah R. Haile, Holger Dressel, Christian Benden
219 [GO] 2020―Aug―11 SARS-CoV-2 seroprevalence in a belgian cohort of patients with cystic fibrosis S. Berardis, A. Verroken, A. Vetillart, C. Struyf, M. Gilbert, D. Gruson, S. Gohy
220 [GO] 2020―Jul―31 The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients. Trudy Havermans, Janne Houben, Francois Vermeulen, Mieke Boon, Marijke Proesmans, Natalie Lorent, et al. (+3)
221 [GO] 2020―Jun―23 No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy Carolina Scagnolari, Camilla Bitossi, Federica Frasca, Agnese Viscido, Giuseppe Oliveto, Mirko Scordio, et al. (+6)
222 [GO] 2020―Jun―08 Healthcare reassessment in a pandemics time: challenges for CF Carlo Castellani
223 [GO] 2020―May―11 COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful Eric Farfour, Clément Picard, Laurence Beaumont, Philippe Lesprit, Marie-Christine Ballester, Felix Ackermann, et al. (+4)
224 [GO] 2020―Apr―25 A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS Rebecca Cosgriff, Susannah Ahern, Scott C. Bell, Keith Brownlee, Pierre-Régis Burgel, Cass Byrnes, et al. (+12)
225 [GO] 2020―Apr―13 Asymptomatic case of Covid-19 in an infant with cystic fibrosis Piercarlo Poli, Silviana Timpano, Martina Goffredo, Rita Padoan, Raffaele Badolato
 [1] 

225 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec